Q: I have a full position in WELL but am also intrigued with DOC based on your recent comments. Can you comment on the new appointments in the recent news release and the pedigree of management. Assuming DOC drops closer to the new bought deal price of $2.40 would you be a buyer here?
Thank you
Thank you